Quel est le prix pour HLS Therapeutics Inc. (HLS)

Le prix pour HLS Therapeutics Inc. (HLS) est $2.75

Quelle est la capitalisation boursière pour HLS Therapeutics Inc. (HLS)

La capitalisation boursière pour HLS Therapeutics Inc. (HLS) est $86.08M

HLS Therapeutics Inc. (HLS) Marge Opérationnelle

HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.

Année	Marge opérationnelle	Changez
Pas assez de données pour les dates fournies.

Année

Marge opérationnelle

Changez

Pas assez de données pour les dates fournies.

Entreprise	Marge opérationnelle	Différence de Marge Opérationnelle	Pays
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	-	DE
Merck KGaA MRK.DE	0.00%	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	-	JP
Galderma Group AG GALD.SW	0.00%	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	22.93%	-	IN

Entreprise

Marge opérationnelle

Différence de Marge Opérationnelle

Pays